OncoTherapy Science, Inc. (4564.T)

JPY 26.0

(-3.7%)

Annual Balance Sheets

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 867.27 Million 1.51 Billion 2.68 Billion 3.36 Billion 5.08 Billion 5.36 Billion
Total Current Assets 817.76 Million 1.42 Billion 2.6 Billion 3.19 Billion 4.87 Billion 5.05 Billion
Cash And Short Term Investments 527.65 Million 1.11 Billion 1.83 Billion 2.89 Billion 4.71 Billion 4.85 Billion
Cash and Cash Equivalents 527.65 Million 1.11 Billion 1.83 Billion 2.89 Billion 4.71 Billion 4.85 Billion
Short Term Investments - - - - - -
Net Receivables 189.1 Million 139.24 Million 418.83 Million 165.98 Million 31.99 Million 28.15 Million
Inventory 73.99 Million 99.61 Million 231.04 Million 41.06 Million 24.92 Million 25.33 Million
Other Current Assets 27.01 Million 65.75 Million 113.76 Million 87.95 Million 107.13 Million 144.25 Million
Total Non-Current Assets 49.5 Million 89.17 Million 84.64 Million 173.99 Million 210.06 Million 311.77 Million
Net PPE - - 17 Thousand 94.93 Million 113.47 Million 200.77 Million
Good Will And Intangible Assets - - - 4.72 Million 6.12 Million 9.37 Million
Good Will - - - - - -
Intangible Assets - - - 4.72 Million 6.12 Million 9.37 Million
Long-Term Investments 49 Million 89 Million 84 Million 74 Million 90 Million 101 Million
Tax Assets - - - 172.33 Million 209.47 Million 310.61 Million
Other Non Current Assets 505.99 Thousand -89 Million 630 Thousand -172 Million -209 Million -310 Million
Other Assets 1.00 - 1000.00 2000.00 2000.00 1000.00
Total Liabilities 513.6 Million 656.27 Million 704.96 Million 291.28 Million 359.59 Million 496.87 Million
Total Current Liabilities 359.59 Million 609.22 Million 604.92 Million 194.92 Million 242.88 Million 367.74 Million
Account Payables - - - - - -
Tax Payables 2.42 Million 69.38 Million 136.53 Million 2.89 Million 77.28 Million 108.46 Million
Short Term Debt - - - - - -
Deferred Revenue 197.43 Million 146.2 Million 22.26 Million - - -
Other Current Liabilities 162.16 Million 463.01 Million 582.65 Million 194.92 Million 242.88 Million 367.74 Million
Total Non Current Liabilities 154.01 Million 47.04 Million 100.04 Million 96.35 Million 116.71 Million 129.12 Million
Long-Term Debt 106.84 Million - - - - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 47.16 Million 47.04 Million 99.7 Million 94.35 Million 113.43 Million 124.51 Million
Other Liabilities 1.00 - - - - -
Total Equity 353.66 Million 855.16 Million 1.98 Billion 3.07 Billion 4.72 Billion 4.87 Billion
Stock Holders Equity 353.66 Million 855.16 Million 1.98 Billion 3.07 Billion 4.72 Billion 4.87 Billion
Common Stock 50 Million 789.11 Million 789.11 Million 50 Million 1.42 Billion 328.36 Million
Retained Earnings -26.09 Billion -24.8 Billion -23.68 Billion -21.11 Billion -19.55 Billion -17.31 Billion
Accumulated other comprehensive income 74.5 Million 77.26 Million 83.68 Million 86.95 Million 176.97 Million 264.49 Million
Common Stock Equity 353.66 Million 855.16 Million 1.98 Billion 3.07 Billion 4.72 Billion 4.87 Billion
Capital Lease Obligation - - - - - -
Total Investments 49 Million 89 Million 84 Million 74 Million 90 Million 101 Million
Total Debt 106.84 Million - - - - -
Net Debt -420.8 Million -1.11 Billion -1.83 Billion -2.89 Billion -4.71 Billion -4.85 Billion

Balance Sheet Charts